| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 12.02.
| Expecting Gilead To Break $70, Outperforming Merck | | 9 | Seeking Alpha |
| 10.02.
| Morgan Stanley startet Gilead Sciences, Celgene und Biogen Idec mit Overweight. | | 97 | BörseGo |
| Morgan Stanley startet Gilead Sciences, Celgene und Biogen Idec mit Overweight.
(© BörseGo AG 2012 - Autor: Thomas Gansneder, Redakteur)
Mehr lesen zu:
Morgan Stanley startet Gilead Sciences, Celgene und Biogen Idec mit Overweight. | |
| 10.02.
| Barclays startet Gilead Sciences mit Overweight. | | 59 | BörseGo |
| Barclays startet Gilead Sciences mit Overweight.
(© BörseGo AG 2012 - Autor: Thomas Gansneder, Redakteur)
Mehr lesen zu:
Barclays startet Gilead Sciences mit Overweight. | |
| 09.02.
| Gilead Sciences to Present at Two Upcoming Investor Conferences | | 44 | Business Wire |
| - 14th Annual BIO CEO &
Investor Conference on February 14th
-
- Leerink Swan Global Healthcare Conference 2012 on February 15th
-
-...
Mehr lesen zu:
Gilead Sciences to Present at Two Upcoming Investor Conferences | |
| 08.02.
| Critical Alerts For Disney, Gilead Sciences, Discover, Sunoco, and LG Display Released By Seven Summits Research | | 29 | PR Newswire |
| CHICAGO, Feb. 8, 2012 /PRNewswire/ --Seven Summits Research issues critical PriceWatch Alerts for DIS, GILD, DFS, SUN, and LPL.
To see what our analysts have discovered about these stocks read the...
Mehr lesen zu:
Critical Alerts For Disney, Gilead Sciences, Discover, Sunoco, and LG Display Released By Seven Summits Research | |
| 07.02.
| Possible Bearish Inside Day Candle Pattern Detected for Gilead Sciences | | 9 | SmarTrend |
| 06.02.
| UBS hebt das Kursziel für Gilead Sciences von $53 qauf $61. | | 92 | BörseGo |
| UBS hebt das Kursziel für Gilead Sciences von $53 qauf $61.
(© BörseGo AG 2012 - Autor: Tobias Krieg, Redakteur)
Mehr lesen zu:
UBS hebt das Kursziel für Gilead Sciences von $53 qauf $61. | |
| 06.02.
| Perception, Opportunity in Volatility - Research & Analysis on Zynga Inc and Gilead Sciences, Inc. | | 23 | MarketWire |
| HONG KONG -- (Marketwire) -- 02/06/12 -- This morning, www.MarketFoundations.com announced new reports highlighting Zynga Inc (NASDAQ: ZNGA) and Gilead Sciences, Inc. (NASDAQ: GILD). Free research...
Mehr lesen zu:
Perception, Opportunity in Volatility - Research & Analysis on Zynga Inc and Gilead Sciences, Inc. | |
| 06.02.
| There's no Stopping Gilead Sciences | | 17 | Motley Fool |
| 06.02.
| Gilead Sciences gibt Finanzergebnisse für viertes Quartal und Gesamtjahr 2011 bekannt | | 163 | Business Wire |
| – Produktumsatz im vierten Quartal steigt mit 2,13 Milliarden
US-Dollar im Jahresvergleich um 11 Prozent –
– Produktumsatz im Gesamtjahr 2011 mit 8,10 Milliarden...
Mehr lesen zu:
Gilead Sciences gibt Finanzergebnisse für viertes Quartal und Gesamtjahr 2011 bekannt | |
| 04.02.
| Uptrend Call Working As Gilead Sciences Stock Rises 31.3% | | 27 | SmarTrend |
| 03.02.
| Movers roundup: Gilead Sciences, Peet's Coffee | | 4 | Yahoo-USA |
| 03.02.
| A drop in the unemployment rate to its lowest in three years propelled the Dow Jones industrial average Friday to its highest close since before the 2008 financial crisis. The Nasdaq composite index hit an 11-year high.Tyson Foods, BB&T, Gilead are market | | 1 | Yahoo-USA |
| 03.02.
| Call Players Show Up on Gilead Sciences Post-Earnings | | 7 | Schaeffer's Research |
| 03.02.
| Gilead Sciences Shares Surged: What You Need to Know | | 14 | Motley Fool |
| 03.02.
| Gilead's Hep C Results Send Shares Sharply Higher | | 8 | Barron's |
| 03.02.
| Gilead Sciences Meets on the Top Line, Misses Where it Counts | | 7 | Motley Fool |
| 03.02.
| Idenix Falls Casualty to Gilead Hep C Hoopla | | 7 | The Street |
| 03.02.
| Gilead Sciences Surging on Clinical Trial Data | | - | Benzinga.com |
| 03.02.
| Gilead Sciences Climbs on Hepatitis C Trial Results: San Francisco Mover | | 10 | Bloomberg |
